Conjugated Pneumococcal Vaccine
Pneumococcal Infection
Minsk Scientific-Practical Center for Surgery, Transplantation and HematologyvaccinePhase 4 / ApprovedDormant
BBB
73/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 59/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Pneumococcal Infection cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Prevenar 13 Poitiers University Hospital | Phase 4 | BBB |
Ppsv23 Poitiers University Hospital | Phase 4 | BB |
Ppsv23 Poitiers University Hospital | Phase 4 | BB |
Prevnar 20 Poitiers University Hospital | Phase 4 | BB |
Prevnar 13 Merck Sharp & Dohme LLC | Phase 3 | BB |
View all 10 →
Same molecule, other indications
Conjugated Pneumococcal Vaccine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →